| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ardelyx, Inc. (ARDX) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. ARDX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 3.30M | $19.98M | - | |
| CEO | 1.74M | $10.53M | -41,666 | |
| Other | 409.9K | $2.48M | - | |
| CFO | 409.1K | $2.47M | - | |
| Other | 339.5K | $2.05M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2024 | Felsch Robert Ora64 | See Remarks | Sell | 2,352 | $8.75 | $20,571.30 | -1.3% | -7.3% | -25.6% | |
| Feb 20, 2024 | Williams Laura A55 | Chief Medical Officer | Sell | 4,803 | $8.75 | $42,008.48 | -1.2% | -7.3% | -25.6% | |
| Feb 8, 2024 | Rosenbaum David P.59 | Chief Development Officer | Sell | 15,344 | $9.18 | $140,845.64 | -3.8% | -8.5% | -39.8% | |
| Jan 8, 2024 | Rosenbaum David P.59 | Chief Development Officer | Sell | 30,000 | $6.64 | $199,200.00 | -9.5% | -10.5% | -33.9% | |
| Dec 26, 2023 | Renz Justin A54 | Chief Financial Officer | Sale+OE | 225,000 | $6.36 | $1,430,122.50 | -55.2% | +19.0% | -25.7% | |
| Dec 18, 2023 | Rosenbaum David P.59 | Chief Development Officer | Sell | 5,675 | $6.07 | $34,447.25 | -1.8% | +24.8% | -25.8% | |
| Dec 14, 2023 | Rosenbaum David P.59 | Chief Development Officer | Sell | 7,000 | $5.55 | $38,850.00 | -2.1% | +49.0% | -10.0% | |
| Dec 11, 2023 | Grammer Elizabeth A58 | See Remarks | Sell | 50,000 | $5.08 | $253,925.00 | -15.4% | +63.9% | +1.7% | |
| Dec 8, 2023 | Rosenbaum David P.59 | Chief Development Officer | Sell | 20,000 | $5.27 | $105,476.00 | -5.7% | +71.5% | +9.4% | |
| Dec 5, 2023 | Rosenbaum David P.59 | Chief Development Officer | Sell | 10,272 | $5.00 | $51,360.00 | -2.9% | +80.1% | +11.2% |